Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -18.84M
March 31, 2026 -20.27M
December 31, 2025 -19.28M
September 30, 2025 -19.32M
June 30, 2025 -21.35M
March 31, 2025 -21.43M
December 31, 2024 -25.47M
September 30, 2024 -13.97M
June 30, 2024 -16.79M
March 31, 2024 -17.52M
December 31, 2023 -17.92M
September 30, 2023 -29.31M
June 30, 2023 -27.27M
March 31, 2023 -26.27M
December 31, 2022 -14.54M
September 30, 2022 -13.89M
June 30, 2022 -12.03M
March 31, 2022 -11.22M
December 31, 2021 -20.37M
September 30, 2021 -18.86M
June 30, 2021 -19.24M
March 31, 2021 -18.29M
December 31, 2020 -16.92M
September 30, 2020 -16.79M
June 30, 2020 -15.76M
Date Value
March 31, 2020 -14.08M
December 31, 2019 -12.94M
September 30, 2019 -13.95M
June 30, 2019 -14.60M
March 31, 2019 -14.73M
December 31, 2018 -14.59M
September 30, 2018 -14.72M
June 30, 2018 -13.01M
March 31, 2018 -12.91M
December 31, 2017 -12.07M
September 30, 2017 -10.27M
June 30, 2017 -9.653M
March 31, 2017 -9.263M
December 31, 2016 -8.755M
September 30, 2016 -8.669M
June 30, 2016 -8.982M
March 31, 2016 -8.472M
December 31, 2015 -8.516M
September 30, 2015 -7.454M
June 30, 2015 -5.925M
March 31, 2015 -5.331M
December 31, 2014 -4.103M
September 30, 2014 -3.809M
June 30, 2014 -3.761M
March 31, 2014 -3.425M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 1.368B
Neogen Corp. 83.20M
QuidelOrtho Corp. -57.20M
Aspira Women's Health, Inc. -4.562M
Lucid Diagnostics, Inc. -46.87M